Form 4 for INSM INSMED Inc
Accepted 2022-03-25 00:00:00 ET · period of report 2022-03-23 · accession 0001140361-22-011256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-25 | 2022-03-23 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $15.56 | +96.6K | 247.9K | +64% | +$1.50M |
| DM | 2022-03-25 | 2022-03-23 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $23.16 | -96.6K | 217.6K | -31% | -$2.24M |
| DM | 2022-03-25 | 2022-03-23 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -96.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-23 | M | A | 65,405 | $16.16 | 283,029 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-23 | S | D | 65,405 | $23.16 | 217,624 | D | — | — | (F3) This is the weighted average sales price representing 65,405 shares sold at prices ranging from $22.61 to $23.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2022-03-23 | M | A | 981 | $16.16 | 218,605 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-23 | S | D | 981 | $23.61 | 217,624 | D | — | — | (F4) This is the weighted average sales price representing 981 shares sold at prices ranging from $23.61 to $23.64 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 5 | Common | Common Stock | 2022-03-23 | M | A | 30,228 | $14.24 | 247,852 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-23 | S | D | 30,228 | $23.16 | 217,624 | D | — | — | (F2) This is the weighted average sales price representing 30,228 shares sold at prices ranging from $22.62 to $23.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Derivative | Stock Option (right to buy) | 2022-03-23 | M | D | 981 | $0.00 | 96,614 | D | $16.16 · — to 2026-01-07 | 981 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 8 | Derivative | Stock Option (right to buy) | 2022-03-23 | M | D | 65,405 | $0.00 | 97,595 | D | $16.16 · — to 2026-01-07 | 65,405 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 9 | Derivative | Stock Option (right to buy) | 2022-03-23 | M | D | 30,228 | $0.00 | 0 | D | $14.24 · — to 2023-10-31 | 30,228 Common Stock | (F5) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |